Importantly, our in silico analysis also showed that increased RPA1 expression at the gene level was correlated with poor survival outcomes in BRAFV600E-mutated patients with colon adenocarcinoma and mucinous adenocarcinoma of the colon. The gene discussed is RPA1; the disease is colon adenocarcinoma.